Matthew Chandler
Matthew Chandler, JD
Matthew Chandler, JD is a Director. He regularly assists life sciences companies in a variety of compliance-related matters, from start-ups developing their initial compliance framework to big pharma clients operating under Corporate Integrity Agreements (CIAs).
Clients often engage Matt to support conducting healthcare compliance and enterprise-wide risk assessments, developing and updating compliance policies and procedures, creating compliance trainings, and to lead auditing and monitoring work. He is also a subject matter expert in physician payment transparency laws and works extensively with companies on transparency-related compliance.
He has had several recent engagements working as an interim compliance officer at various pharmaceutical and biotech companies, where he has helped develop the foundation of the companies’ compliance program and led various compliance workstreams.
Matt also has extensive experience supporting complex and data-intensive investigations and disputes involving the pharmaceutical, medical device, and diagnostic industries. Particular allegations at issue in cases Matt has supported include violations of the Anti-Kickback Statute, False Claims Act, Physician Payments Sunshine Act, Stark Law, and FDA-related regulations. He has also been a member of several Independent Review Organizations (IROs) for companies under CIA and has conducted systems and transactions reviews for numerous activities outlined by the Office of Inspector General (OIG).
Prior to starting his consulting career, Matt was the regulatory analyst and head writer for Policy and Medicine, a prominent life sciences publication with a focus on analyzing government enforcement trends, FDA activity, and transparency requirements.
Matt attended the College of William and Mary for his undergraduate and received his Juris Doctor from the University of Arizona, where he served as an Articles Editor for the Arizona Law Review.